Kumar Neil 4
4 · BridgeBio Pharma, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
BridgeBio (BBIO) CEO Neil Kumar Sells 80,000 Shares
What Happened
Neil Kumar, CEO of BridgeBio Pharma (BBIO), sold a total of 80,000 shares in open-market transactions on February 10–11, 2026 for aggregate proceeds of approximately $5.75 million. He sold 40,000 shares on Feb 10 and 40,000 shares on Feb 11 at prices ranging roughly from $70.69 to $73.25 per share across multiple trades.
Key Details
- Transaction dates: Feb 10, 2026 and Feb 11, 2026. Prices per trade ranged ~ $70.69–$73.25.
- Shares sold: 80,000 total (40,000 on Feb 10; 40,000 on Feb 11). Proceeds ≈ $5,748,664.
- Shares owned after transaction: Not specified in the excerpt provided.
- Notable footnotes: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted March 31, 2025 (prearranged plan). The filing also includes weighted‑average price ranges for groups of the sales and a disclaimer regarding beneficial ownership of certain shares. The footnotes say detailed per‑price breakdowns can be provided on request.
- Timeliness: Filing dated Feb 12, 2026; appears to be timely under Form 4 reporting rules.
Context
- These were open‑market sales executed under a 10b5‑1 plan, which are prearranged and commonly used by insiders to sell shares on a set schedule. Such sales are generally viewed as routine and do not necessarily indicate the insider’s current view of the company.
- For retail investors: purchases typically carry more weight as a bullish signal than routine, preplanned sales. This filing is informational—if you need the exact per‑trade price breakdown noted in the footnotes, the filer can provide it upon request.
Insider Transaction Report
Form 4
Kumar Neil
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-02-10$71.80/sh−14,201$1,019,657→ 701,485 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-02-10$72.28/sh−5,799$419,165→ 695,686 total(indirect: By Trust) - Sale
Common Stock
[F1][F5][F3]2026-02-10$71.80/sh−14,040$1,008,006→ 4,504,407 total(indirect: By Trust) - Sale
Common Stock
[F1][F6][F3]2026-02-10$72.27/sh−5,960$430,751→ 4,498,447 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F3]2026-02-11$70.69/sh−7,806$551,796→ 687,880 total(indirect: By Trust) - Sale
Common Stock
[F1][F8][F3]2026-02-11$71.44/sh−3,716$265,477→ 684,164 total(indirect: By Trust) - Sale
Common Stock
[F1][F9][F3]2026-02-11$72.64/sh−4,484$325,695→ 679,680 total(indirect: By Trust) - Sale
Common Stock
[F1][F10][F3]2026-02-11$73.25/sh−3,994$292,574→ 675,686 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F3]2026-02-11$70.70/sh−7,860$555,706→ 4,490,587 total(indirect: By Trust) - Sale
Common Stock
[F1][F11][F3]2026-02-11$71.46/sh−3,775$269,754→ 4,486,812 total(indirect: By Trust) - Sale
Common Stock
[F1][F12][F3]2026-02-11$72.65/sh−4,404$319,938→ 4,482,408 total(indirect: By Trust) - Sale
Common Stock
[F1][F13][F3]2026-02-11$73.25/sh−3,961$290,145→ 4,478,447 total(indirect: By Trust)
Holdings
- 228,776
Common Stock
Footnotes (13)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
- [F10]Represents the weighted average sale price of the shares sold from $73.09 to $73.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F11]Represents the weighted average sale price of the shares sold from $71.1 to $72.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F12]Represents the weighted average sale price of the shares sold from $72.1 to $73.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F13]Represents the weighted average sale price of the shares sold from $73.1 to $73.4 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F2]Represents the weighted average sale price of the shares sold from $71.08 to $72.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
- [F4]Represents the weighted average sale price of the shares sold from $72.08 to $72.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F5]Represents the weighted average sale price of the shares sold from $71.02 to $72.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F6]Represents the weighted average sale price of the shares sold from $72.02 to $72.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F7]Represents the weighted average sale price of the shares sold from $70.09 to $71.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F8]Represents the weighted average sale price of the shares sold from $71.09 to $72.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F9]Represents the weighted average sale price of the shares sold from $72.09 to $73.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Signature
/s/ Will Solis, Attorney-in-Fact|2026-02-12